Ghrelin ameliorates hypoxia-induced pulmonary hypertension via phospho-GSK3β/β-catenin signaling in neonatal rats

Journal of Molecular Endocrinology

Volumn 47, Issue 1, 2011, Pages 33-43

  Xu, Yan Ping ^a   Zhu, Jia Jun ^a,b   Cheng, Fen ^a   Jiang, Ke Wen ^a   Gu, Wei Zhong ^a   Shen, Zheng ^a   Wu, Yi Dong ^a   Liang, Li ^a   Du, Li Zhong ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Zhejiang University School of Medicine   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; GHRELIN; GLYCOGEN SYNTHASE KINASE 3BETA; GROWTH HORMONE SECRETAGOGUE RECEPTOR; SODIUM CHLORIDE;

AMBIENT AIR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY WALL; ARTICLE; CELL CULTURE; CELL NUCLEUS; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HEART VENTRICLE HYPERTROPHY; HEMODYNAMICS; HYPOXIA; LUNG ARTERY PRESSURE; MORPHOMETRICS; NEWBORN; NEWBORN PERIOD; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; RAT; SIGNAL TRANSDUCTION; TISSUE REGENERATION;

ACTINS; ANIMALS; ANIMALS, NEWBORN; ANOXIA; APOPTOSIS; BETA CATENIN; BODY WEIGHT; CELLS, CULTURED; GENE EXPRESSION; GHRELIN; GLYCOGEN SYNTHASE KINASE 3; HEMODYNAMICS; HUMANS; INFANT, NEWBORN; LUNG; PERSISTENT FETAL CIRCULATION SYNDROME; PHOSPHORYLATION; PROTEIN TRANSPORT; PULMONARY ARTERY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GHRELIN; SIGNAL TRANSDUCTION;

EID: 79961000837     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-10-0143     Document Type: Article

References (43)

1. Blanco LN, Massaro D & Massaro GD 1991 Alveolar size, number, and surface area: developmentally dependent response to 13% O2. American Journal of Physiology 261 L370-L377.
2. Chanoine JP, De Waele K & Walia P 2009 Ghrelin and the growth hormone secretagogue receptor in growth and development. International Journal of Obesity 33 (Supplement 1) S48-S52. (doi:10.1038/ijo.2009.17)
3. Clark RH, Kueser TJ, Walker MW, Southgate WM, Huckaby JL, Perez JA, Roy BJ, Keszler M & Kinsella JP 2000 Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. New England Journal of Medicine 342 469-474. (doi:10.1056/NEJM200002173420704)
4. Cohen ED, Ihida-Stansbury K, Lu MM, Panettieri RA, Jones PL & Morrisey EE 2009 Wnt signaling regulates smooth muscle precursor development in the mouse lung via a tenascin C/PDGFR pathway. Journal of Clinical Investigation 119 2538-2549. (doi:10.1172/JCI38079)
5. Dasgupta C, Sakurai R, Wang Y, Guo P, Ambalavanan N, Torday JS & Rehan VK 2009 Hyperoxia-induced neonatal rat lung injury involves activation of TGF-{beta} and Wnt signaling and is protected by rosiglitazone. American Journal of Physiology. Lung Cellular and Molecular Physiology 296 L1031-L1041. (doi:10.1152/ajplung. 90392.2008)
6. Deruelle P, Balasubramaniam V, Kunig AM, Seedorf GJ, Markham NE & Abman SH 2006. BAY41-2272, a direct activator of soluble guanylate cyclase, reduces right ventricular hypertrophy and prevents pulmonary vascular remodeling during chronic hypoxia in neonatal rats. Biology of the Neonate 90 135-144. (doi:10.1159/000092518)
7. Dumitrascu R, Weissmann N, Ghofrani HA, Dony E, Beuerlein K, Schmidt H, Stasch JP, Gnoth MJ, Seeger W, Grimminger F et al. 2006 Activation of soluble guanylate cyclase reverses experimental pulmonary hypertension and vascular remodeling. Circulation 113 286-295. (doi:10.1161/CIRCULATIONAHA.105.581405)
8. Eisenberg LM & Eisenberg CA 2007 Evaluating the role of Wnt signal transduction in promoting the development of the heart. Scientific World Journal 7 161-176. (doi:10.1100/tsw.2007.71)
9. Flozak AS, Lam AP, Russell S, Jain M, Peled ON, Sheppard KA, Beri R, Mutlu GM, Budinger GR & Gottardi CJ 2010 Beta-catenin/T-cell factor signaling is activated during lung injury and promotes the survival andmigration of alveolar epithelial cells. Journal of Biological Chemistry 285 3157-3167. (doi:10.1074/jbc.M109.070326)
10. Gien J, Seedorf GJ, Balasubramaniam V, Markham N & Abman SH 2007 Intrauterine pulmonary hypertension impairs angiogenesis in vitro: role of vascular endothelial growth factor nitric oxide signaling. American Journal of Respiratory and Critical Care Medicine 176 1146-1153. (doi:10.1164/rccm.200705-750OC)
11. Gnanapavan S, Kola B, Bustin SA, Morris DG, McGee P, Fairclough P, Bhattacharya S, Carpenter R, Grossman AB & Korbonits M 2002 The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. Journal of Clinical Endocrinology and Metabolism 87 2988. (doi:10.1210/jc.87.6.2988)
12. Henriques-Coelho T, Correia-Pinto J, Roncon-Albuquerque R Jr, Baptista MJ, Lourenco AP, Oliveira SM, Brandao-Nogueira A, Teles A, Fortunato JM & Leite-Moreira AF 2004 Endogenous production of ghrelin and beneficial effects of its exogenous administration in monocrotaline-induced pulmonary hypertension. American Journal of Physiology. Heart and Circulatory Physiology 287 H2885-H2890. (doi:10.1152/ajpheart.01122.2003)
13. Henriques-Coelho T, Roncon-Albuquerque Junior R, Lourenco AP, Baptista MJ, Oliveira SM, Brandao-Nogueira A, Correia-Pinto J & Leite-Moreira AF 2006 Ghrelin reverses molecular, structural and hemodynamic alterations of the right ventricle in pulmonary hypertension. Revista Portuguesa de Cardiologia 25 55-63.
14. Hirenallur SD, Haworth ST, Leming JT, Chang J, Hernandez G, Gordon JB & Rusch NJ 2008 Upregulation of vascular calcium channels in neonatal piglets with hypoxia-induced pulmonary hypertension. American Journal of Physiology. Lung Cellular and Molecular Physiology 295 L915-L924. (doi:10.1152/ajplung.90286. 2008)
15. Hou Y, An J, Hu XR, Sun BB, Lin J, Xu D, Wang T & Wen FQ 2009 Ghrelin inhibits interleukin-8 production induced by hydrogen peroxide in A549 cells via NF-kappaB pathway. International Immunopharmacology 9 120-126. (doi:10.1016/j.intimp.2008.10.020)
16. Iantorno M, Chen H, Kim JA, Tesauro M, Lauro D, Cardillo C & Quon MJ 2007 Ghrelin has novel vascular actions that mimic PI 3-kinase-dependent actions of insulin to stimulate production of NO from endothelial cells. American Journal of Physiology. Endocrinology and Metabolism 292 E756-E764. (doi:10.1152/ajpendo. 00570.2006)
17. de Jesus Perez VA, Alastalo TP, Wu JC, Axelrod JD, Cooke JP, Amieva M & Rabinovitch M 2009 Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt-beta-catenin and Wnt-RhoA-Rac1 pathways. Journal of Cell Biology 184 83-99. (doi:10.1083/jcb. 200806049)
18. John TA, Ibe BO & Usha Raj J 2006 Oxygen alters caveolin-1 and nitric oxide synthase-3 functions in ovine fetal and neonatal lung microvascular endothelial cells. American Journal of Physiology. Lung Cellular and Molecular Physiology 291 L1079-L1093. (doi:10.1152/ ajplung.00526.2005)
19. Keith IM, Tjen ALS, Kraiczi H & Ekman R 2000 Three-week neonatal hypoxia reduces blood CGRP and causes persistent pulmonary hypertension in rats. American Journal of Physiology. Heart and Circulatory Physiology 279 H1571-H1578.
20. Kerkela R, Woulfe K & Force T 2007 Glycogen synthase kinase-3beta - actively inhibiting hypertrophy. Trends in Cardiovascular Medicine 17 91-96. (doi:10.1016/j.tcm.2007.01.004)
21. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H & Kangawa K 1999 Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 656-660. (doi:10.1038/45230)
22. Konigshoff M & Eickelberg O 2010 WNT signaling in lung disease: a failure or a regeneration signal? American Journal of Respiratory Cell and Molecular Biology 42 21-31. (doi:10.1165/rcmb.2008-0485TR)
23. Kranenburg AR, De Boer WI, Van Krieken JH, Mooi WJ, Walters JE, Saxena PR, Sterk PJ & Sharma HS 2002 Enhanced expression of fibroblast growth factors and receptor FGFR-1 during vascular remodeling in chronic obstructive pulmonary disease. American Journal of Respiratory Cell and Molecular Biology 27 517-525. (doi:10.1165/rcmb.4474)
24. De Langhe SP & Reynolds SD 2008 Wnt signaling in lung organogenesis. Organogenesis 4 100-108. (doi:10.4161/org.4.2. 5856)
25. De Langhe SP, Sala FG, Del Moral PM, Fairbanks TJ, Yamada KM, Warburton D, Burns RC & Bellusci S 2005 Dickkopf-1 (DKK1) reveals that fibronectin is a major target of Wnt signaling in branching morphogenesis of the mouse embryonic lung. Developmental Biology 277 316-331. (doi:10.1016/j.ydbio.2004.09.023)
26. Laumanns IP, Fink L, Wilhelm J, Wolff JC, Mitnacht-Kraus R, Graef-Hoechst S, Stein MM, Bohle RM, Klepetko W, Hoda MA et al. 2009 The noncanonical WNT pathway is operative in idiopathic pulmonary arterial hypertension. American Journal of Respiratory Cell and Molecular Biology 40 683-691. (doi:10.1165/rcmb.2008-0153OC).
27. van der Lely AJ 2009 Ghrelin and new metabolic frontiers. Hormone Research 71 (Supplement 1) 129-133. (doi:10.1159/000178055)
28. Liu J, Wang H, Zuo Y & Farmer SR 2006 Functional interaction between peroxisome proliferator-activated receptor gamma and beta-catenin. Molecular and Cellular Biology 26 5827-5837. (doi:10. 1128/MCB.00441-06)
29. Massaro GD, Olivier J & Massaro D 1989 Short-term perinatal 10% O2 alters postnatal development of lung alveoli. American Journal of Physiology 257 L221-L225.
30. Muccioli G, Baragli A, Granata R, Papotti M & Ghigo E 2007 Heterogeneity of ghrelin/growth hormone secretagogue receptors. Toward the understanding of the molecular identity of novel ghrelin/GHS receptors. Neuroendocrinology 86 147-164. (doi:10. 1159/000105141)
31. Nagaya N, Kojima M, Uematsu M, Yamagishi M, Hosoda H, Oya H, Hayashi Y & Kangawa K 2001 Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 280 R1483-R1487.
32. Nagy II, Railo A, Rapila R, Hast T, Sormunen R, Tavi P, Rasanen J & Vainio SJ 2010 Wnt-11 signalling controls ventricular myocardium development by patterning N-cadherin and beta-catenin expression. Cardiovascular Research 85 100-109. (doi:10.1093/cvr/ cvp254)
33. Rossi F, Castelli A, Bianco MJ, Bertone C, Brama M & Santiemma V 2008 Ghrelin induces proliferation in human aortic endothelial cells via ERK1/2 and PI3K/Akt activation. Peptides 29 2046-2051. (doi:10.1016/j.peptides.2008.07.002)
34. Schermuly RT, Kreisselmeier KP, Ghofrani HA, Samidurai A, Pullamsetti S, Weissmann N, Schudt C, Ermert L, Seeger W & Grimminger F 2004 Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension. Circulation Research 94 1101-1108. (doi:10.1161/01.RES.0000126050.41296.8E)
35. Schermuly RT, Dony E, Ghofrani HA, Pullamsetti S, Savai R, Roth M, Sydykov A, Lai YJ, Weissmann N, Seeger W et al. 2005 Reversal of experimental pulmonary hypertension by PDGF inhibition. Journal of Clinical Investigation 115 2811-2821. (doi:10.1172/JCI24838)
36. Schwenke DO, Tokudome T, Shirai M, Hosoda H, Horio T, Kishimoto I & Kangawa K 2008 Exogenous ghrelin attenuates the progression of chronic hypoxia-induced pulmonary hypertension in conscious rats. Endocrinology 149 237-244. (doi:10.1210/en.2007-0833)
37. Van Scoyk M, Randall J, Sergew A, Williams LM, Tennis M & Winn RA 2008 Wnt signaling pathway and lung disease. Translational Research 151 175-180. (doi:10.1016/j.trsl.2007.12.011)
38. Takayasu H, Nakazawa N, Montedonico S & Puri P 2007 Downregulation of Wnt signal pathway in nitrofen-induced hypoplastic lung. Journal of Pediatric Surgery 42 426-430. (doi:10.1016/ j.jpedsurg.2006.10.018)
39. Tang JR, Le Cras TD, Morris KG Jr & Abman SH 2000 Brief perinatal hypoxia increases severity of pulmonary hypertension after reexposure to hypoxia in infant rats. American Journal of Physiology. Lung Cellular and Molecular Physiology 278 L356-L364.
40. Volante M, Fulcheri E, Allia E, Cerrato M, Pucci A & Papotti M 2002 Ghrelin expression in fetal, infant, and adult human lung. Journal of Histochemistry and Cytochemistry 50 1013-1021. (doi:10.1177/002215540205000803)
41. Wang X, Liang L & Du L 2007 The effects of intrauterine undernutrition on pancreas ghrelin and insulin expression in neonate rats. Journal of Endocrinology 194 121-129. (doi:10.1677/JOE-07-0057)
42. Wiley KE & Davenport AP 2002 Comparison of vasodilators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin-1. British Journal of Pharmacology 136 1146-1152. (doi:10.1038/sj.bjp.0704815)
43. Xu X, Jhun BS, Ha CH & Jin ZG 2008 Molecular mechanisms of ghrelin-mediated endothelial nitric oxide synthase activation. Endocrinology 149 4183-4192. (doi:10.1210/en.2008-0255)